SM04646
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Biosplice Therapeutics, Inc.
Overview
SM04646 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
SM04646 clinical trials
Explore related
Medical disclaimer. This page summarizes research about SM04646 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.